BNY Mellon Sm/Md Cp Gr Y holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
BNY Mellon Small/Mid Cap Growth Fund Class Y DBMYX
- NAV / 1-Day Return 24.50 / +2.55 %
- Total Assets 811.6M
-
Adj. Expense Ratio
0.690%
- Expense Ratio 0.640%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 131%
USD | NAV as of Aug 08, 2026 | 1-Day Return as of Aug 08, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DBMYX
Will DBMYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Repligen Corp | 3.44 | 30M | Healthcare |
The Baldwin Insurance Group Inc Class A | 3.23 | 28M | Financial Services |
Guardant Health Inc | 3.19 | 28M | Healthcare |
Construction Partners Inc Class A | 3.17 | 27M | Industrials |
Casey's General Stores Inc | 2.91 | 25M | Consumer Cyclical |
Bel Fuse Inc Class B | 2.89 | 25M | Technology |
Regal Rexnord Corp | 2.78 | 24M | Industrials |
Wingstop Inc | 2.64 | 23M | Consumer Cyclical |
Curtiss-Wright Corp | 2.63 | 23M | Industrials |
Herc Holdings Inc | 2.58 | 22M | Industrials |